We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ocular Sciences (OCLR) -- Ignore unavailable to you. Want to Upgrade?

To: Manish Aurora who wrote (23)6/4/2000 2:33:00 AM
From: Paul Senior  Read Replies (1) | Respond to of 36
Anyone here adding to their position in OCLR now?

The way I see it: WJCO was willing to pay about $18 in stock. With the termination, OCLR's $25M gives OCLR roughly another $1 sh (before any taxes)on the balance sheet. With OCLR's stock at about 13 5/8, maybe OCLR is worth $19? Given the consolidation in the industry and OCLR's niche in it, is the future still bright for OCLR?

Paul Senior,
Seeking information/opinions. I have no position in this stock.